Ruxolitinib for myelofibrosis: The earlier, the better?

Cancer. 2024 Dec 15;130(24):4224-4226. doi: 10.1002/cncr.35592. Epub 2024 Oct 13.

Authors

Prithviraj Bose¹, Pankit Vachhani²

Affiliations

¹ Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
² Department of Medicine, Division of Hematology and Oncology, The University of Alabama at Birmingham, Birmingham, Alabama, USA.

PMID: 39396121
DOI: 10.1002/cncr.35592

No abstract available

Publication types

Editorial

Grants and funding